BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26469347)

  • 21. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus.
    Ernould JC; Ba K; Sellin B
    Acta Trop; 1999 Jul; 73(2):143-52. PubMed ID: 10465054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micro-geographical heterogeneity in Schistosoma mansoni and S. haematobium infection and morbidity in a co-endemic community in northern Senegal.
    Meurs L; Mbow M; Boon N; van den Broeck F; Vereecken K; Dièye TN; Abatih E; Huyse T; Mboup S; Polman K
    PLoS Negl Trop Dis; 2013; 7(12):e2608. PubMed ID: 24386499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
    Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
    BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
    Aboagye IF; Addison YAA
    Pathog Glob Health; 2023 Oct; 117(7):623-630. PubMed ID: 36394218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
    Koukounari A; Donnelly CA; Sacko M; Keita AD; Landouré A; Dembelé R; Bosqué-Oliva E; Gabrielli AF; Gouvras A; Traoré M; Fenwick A; Webster JP
    BMC Infect Dis; 2010 Jul; 10():227. PubMed ID: 20670408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria.
    Ojo JA; Adedokun SA; Akindele AA; Olorunfemi AB; Otutu OA; Ojurongbe TA; Thomas BN; Velavan TP; Ojurongbe O
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009628. PubMed ID: 34314428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa.
    Ndeffo Mbah ML; Skrip L; Greenhalgh S; Hotez P; Galvani AP
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3234. PubMed ID: 25329403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.
    Dejon-Agobé JC; Edoa JR; Honkpehedji YJ; Zinsou JF; Adégbitè BR; Ngwese MM; Mangaboula A; Lell B; Woldearegai TG; Grobusch MP; Mordmüller B; Adegnika AA
    Parasit Vectors; 2019 Dec; 12(1):577. PubMed ID: 31823806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of case management in the integrated schistosomiasis-control programme in Mali.
    Landouré A; van der Werf MJ; Traoré M; de Vlas SJ
    Ann Trop Med Parasitol; 2003 Oct; 97(7):723-36. PubMed ID: 14613631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.
    Senghor B; Diaw OT; Doucoure S; Seye M; Diallo A; Talla I; Bâ CT; Sokhna C
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004557. PubMed ID: 27015646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
    Ben SA; Useh MF
    Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal parasitoses and schistosome infections among students with special reference to praziquantel efficacy in patients with schistosomosis in Hajjah governorate, Yemen.
    Alharbi RA; Alwajeeh TS; Assabri AM; Almalki SSR; Alruwetei A; Azazy AA
    Ann Parasitol; 2019; 65(3):217-223. PubMed ID: 31578845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of staff performance and material resources for integrated schistosomiasis control in northern Senegal.
    van der Werf MJ; Mbaye A; Sow S; Gryseels B; de Vlas SJ
    Trop Med Int Health; 2002 Jan; 7(1):70-9. PubMed ID: 11851957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rice irrigation and schistosomiasis in savannah and forest areas of Côte d'Ivoire.
    Yapi YG; Briët OJ; Diabate S; Vounatsou P; Akodo E; Tanner M; Teuscher T
    Acta Trop; 2005 Feb; 93(2):201-11. PubMed ID: 15652334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.
    Gryseels B; Mbaye A; De Vlas SJ; Stelma FF; Guissé F; Van Lieshout L; Faye D; Diop M; Ly A; Tchuem-Tchuenté LA; Engels D; Polman K
    Trop Med Int Health; 2001 Nov; 6(11):864-73. PubMed ID: 11703840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of praziquantel against Schistosoma haematobium infection in children.
    Tchuenté LA; Shaw DJ; Polla L; Cioli D; Vercruysse J
    Am J Trop Med Hyg; 2004 Dec; 71(6):778-82. PubMed ID: 15642971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
    Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
    BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.